More than half of the patients with cerebral aneurysms have combined primary hypertension, which is closely related to the occurrence, development and rupture of aneurysms. According to the latest Expert Consensus on the Management of Severe Aneurysmal Subarachnoid Hemorrhage, patients should have their systolic blood pressure controlled between 140 and 160 mmHg before surgery, as high blood pressure increases the risk of aneurysm rebleeding, while low blood pressure may lead to insufficient cerebral perfusion and ischemic brain damage. After surgery, the patient’s blood pressure should be adjusted according to the patient’s basal blood pressure. The adjustment of blood pressure during the perioperative period is the task of the medical and nursing staff and does not require the patient’s concern; however, the treatment of hypertension after discharge requires the patient to undergo systematic and long-term medical drug control according to medical advice, which is often a lifelong task for the patient. Patients with poorly controlled hypertension require prompt consultation with the cardiology department. In addition to antihypertensive medications, some patients also require long-term antiplatelet medications. This is mainly a group of patients who have had stents placed during aneurysm embolization, and the role of antiplatelet medications is to prevent the formation of blood clots within the stents. Two types of antiplatelet drugs are commonly used, aspirin and poliovirus, and the two drugs are usually combined for a period of 1 to 3 months, after which poliovirus is discontinued and aspirin is taken orally for a long period of time. The use of both drugs should strictly follow the doctor’s prescription, and the doctor will adjust the dosage of antiplatelet drugs according to the patient’s vascular condition, platelet function, aneurysm embolism, stent type, clinical symptoms and other factors.